unknown
Stage
1
Investors
About
Borea Therapeutics develops innovative therapeutic options for patients with genetic or chronic diseases using next-generation viral vectors, leveraging a proprietary click chemistry platform to chemically modify adeno-associated virus (AAV) vectors.
Explore Borea Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.